TRVN

0.00050.00%
BY

Barbara Yanni

Independent Director

Ms. Barbara Yanni, J.D., M.A., B.A., LLM, serves as Non-Executive Director at Pharming Group N.V. since December 11, 2020. Ms. Yanni served as an Independent Director at Oncorus, Inc. since July 27, 2021 until July 28, 2023. Ms. Yanni serves as Independent Director at Trevena, Inc. and Mesentech, Inc., from November 2020, a private biotechnology company. She had been Independent Director at Akcea Therapeutics, Inc. since December 13, 2019 until October 12, 2020. She served as the Chief Licensing Officer and Vice President of Merck & Co., Inc., from November 2001 to March 2014. Ms. Yanni had a career at Merck & Co., Inc., before her retirement in March 2014. She served as an Independent Director at Vaccinex, Inc. since February 2015 until 2025. Before joining Merck in 1985, she was a tax lawyer in New York City. She has been an Independent Director at Trevena, Inc. since July 1, 2014. She also serves on the board of a privately held biopharmaceutical company. Ms. Yanni served as a Director of Abionyx Pharma (formerly known as Cerenis Therapeutics, SA) from July 2018 to January 2020 and a privately held biopharmaceutical company, Symic Bio, Incorporated from February 2015 to August 2019. Ms. Yanni received an A. B. in Physics from Wellesley College, a J. D. from Stanford Law School and an LL.M in Taxation from New York University.

Positions